Endovascular Aneurysm Repair (EVAR) Market

Endovascular Aneurysm Repair (EVAR) Market Size, Market Forecast and Outlook By FMI

The endovascular aneurysm repair (evar) market was valued at USD 3.30 billion in 2025, projected to reach USD 3.46 billion in 2026, and is forecast to expand to USD 5.53 billion by 2036 at a 4.8% CAGR. Aging populations in developed economies and expanding access to catheterization laboratories in emerging markets are sustaining procedural volume growth for endovascular aneurysm repair. FMI analysts note that fenestrated and branched EVAR techniques are gaining clinical adoption for complex aortic anatomies that were previously managed through open surgical repair, widening the addressable patient pool.

Summary of Endovascular Aneurysm Repair (EVAR) Market

• Market Overview
  • The market is valued at USD 3.30 billion in 2025 and is projected to reach USD 5.53 billion by 2036.
  • The industry is expected to grow at a 4.8% CAGR from 2026 to 2036, creating an incremental opportunity of USD 2.07 billion.
  • The market is a procedural medical device category where graft customization capability, clinical evidence maturity, and physician training infrastructure define competitive positioning across vascular surgery centers.
• Demand and Growth Drivers
  • Demand is rising as aging populations in developed economies and expanding diagnostic imaging access in emerging markets increase aneurysm detection and treatment volumes.
  • Fenestrated and branched EVAR techniques are expanding the addressable patient pool by enabling endovascular treatment of complex aortic anatomies previously requiring open surgical repair.
  • Percutaneous access techniques are reducing procedure complexity and recovery times, lowering the threshold for EVAR intervention across community hospital settings.
  • Among countries, China (6.5% CAGR), India (6% CAGR), Germany (5.5% CAGR), France (5% CAGR), UK (4.6% CAGR), USA (4.1% CAGR), Brazil (3.6% CAGR).
• Product and Segment View
  • Fenestrated EVAR leads by Techniques with 32.2% share in 2026.
  • Gender leads by Demographics with 52.7% share in 2026.
• Geography and Competitive Outlook
  • China and India are the fastest growing markets, while mature economies sustain demand through technology upgrade and compliance driven procurement cycles.
  • Key players include Cardinal Health Inc, Lombard Medical Inc, W. L. Gore & Associates Inc, Medtronic Plc, Koninklijke Philips N.V., Endologix Inc, Abbott Laboratories.
• Analyst Opinion at FMI
  • Sabyasachi Ghosh, Principal Consultant for Medical Devices, opines: 'In my analysis, I have observed that the EVAR market is shifting from standard infrarenal grafts toward fenestrated and branched systems that address complex juxta-renal and thoracoabdominal anatomies. Device manufacturers who cannot deliver physician customizable fenestrated grafts with rapid turnaround times are losing procedural share in tertiary vascular centers where complex cases generate the highest per procedure device revenue.'
• Strategic Implications / Executive Takeaways
  • Device manufacturers must invest in physician customizable fenestrated and branched graft platforms to capture growing complex EVAR procedural volumes at tertiary vascular centers.
  • Hospital vascular service line directors should evaluate percutaneous EVAR training programs to reduce femoral access site complications and shorten patient recovery times.
  • Health system procurement teams need to negotiate volume based pricing agreements with graft manufacturers as procedural volumes shift from open surgical repair to endovascular approaches.

Endovascular Aneurysm Repair (EVAR) Market Key Takeaways

Metric	Details
Industry Size (2026)	USD 3.46 Billion
Industry Value (2036)	USD 5.53 Billion
CAGR (2026 to 2036)	4.8%

Source: Future Market Insights, 2026

The incremental opportunity of USD 2.07 billion between 2026 and 2036 reflects the compound effect of rising aneurysm detection rates through incidental imaging, expanding indications for fenestrated and branched graft technologies, and growing adoption of percutaneous access techniques that reduce recovery times. Hospital systems are transitioning from open surgical repair toward EVAR as the default intervention for abdominal aortic aneurysms, supported by clinical evidence demonstrating lower perioperative morbidity. Reimbursement frameworks in the USA and Germany continue to support graft and device costs at levels that sustain manufacturer investment in next generation delivery systems.

All major regional markets reflect differentiated growth trajectories. China leads with a 6.5% CAGR, India follows at 6%, Germany follows at 5.5%, France follows at 5%, UK follows at 4.6%, USA follows at 4.1%, and Brazil registers 3.6% growth. China's lead growth rate reflects rapid catheterization laboratory expansion and growing vascular surgery training programs. India's pace is supported by rising diagnostic imaging access that identifies previously undetected aneurysms. Germany and France maintain growth through established vascular surgery referral networks and favorable reimbursement for complex fenestrated procedures.

Endovascular Aneurysm Repair (EVAR) Market Definition

The endovascular aneurysm repair (EVAR) market encompasses medical devices and graft systems used to treat aortic aneurysms through minimally invasive catheter based techniques. Procedures include fenestrated EVAR, adjunctive EVARs, branched EVAR, percutaneous EVAR, and hybrid approaches. These devices are deployed through femoral artery access to deliver stent grafts that exclude the aneurysm sac from systemic blood flow, avoiding the morbidity of open surgical repair.

Endovascular Aneurysm Repair (EVAR) Market Inclusions

Market scope includes stent graft systems, delivery catheters, and ancillary devices used in endovascular aneurysm repair procedures. Global and regional market sizes, technique and demographic segment breakdowns, and forecast projections from 2026 to 2036 are covered.

Endovascular Aneurysm Repair (EVAR) Market Exclusions

The scope excludes open surgical aortic repair devices, diagnostic imaging equipment, catheterization laboratory infrastructure, and endovascular devices used exclusively for peripheral or cerebrovascular indications not involving aneurysm repair.

Endovascular Aneurysm Repair (EVAR) Market Research Methodology

• Primary Research: Analysts engaged with vascular surgery department heads, interventional radiology directors, and hospital procurement managers to map device selection criteria, procedural volume trends, and graft technology preferences.
• Desk Research: Data collection aggregated published clinical registry data, medical device regulatory approval timelines, national vascular surgery society guidelines, and hospital procedural volume databases.
• Market Sizing and Forecasting: Baseline values derive from a bottom up aggregation of EVAR procedural volumes by technique type, applying regional device pricing benchmarks and graft utilization ratios to project market growth.
• Data Validation and Update Cycle: Projections are tested against published vascular registry procedural counts, medical device manufacturer revenue disclosures, and hospital capital equipment procurement records.

Why is the Endovascular Aneurysm Repair (EVAR) Market Growing?

The Endovascular Aneurysm Repair market is growing steadily, supported by increasing prevalence of abdominal aortic aneurysms and advancements in minimally invasive surgical procedures. Rising awareness among patients and physicians regarding the benefits of EVAR over traditional open surgeries, such as reduced hospital stays, lower procedural risks, and faster recovery times, is fueling adoption. The market is also benefiting from continuous technological improvements in stent graft design, imaging systems, and navigation tools that enhance surgical precision and long-term outcomes.

Growing geriatric populations worldwide, who are more prone to aneurysm formation, are driving demand further. Additionally, increasing healthcare expenditure, rising screening programs, and government initiatives focused on improving vascular disease management are expanding treatment accessibility.

The emergence of customized grafts and patient-specific EVAR solutions tailored to anatomical variations is adding momentum to market growth As the burden of cardiovascular diseases continues to rise globally, EVAR is expected to remain a preferred treatment option, positioning the market for sustained expansion in both developed and emerging economies.

Segmental Analysis

The endovascular aneurysm repair (evar) market is segmented by techniques, demographics, and geographic regions. By techniques, endovascular aneurysm repair (evar) market is divided into Fenestrated EVAR, Adjunctive EVARs, Branched EVAR, Percutaneous EVAR, and Hybrid Procedures. In terms of demographics, endovascular aneurysm repair (evar) market is classified into Gender (Men And Women) and Age (Paediatric, Adult And Geriatric). Regionally, the endovascular aneurysm repair (evar) industry is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.

Insights into the Fenestrated EVAR Techniques Segment

The fenestrated EVAR techniques segment is projected to hold 32.2% of the market revenue share in 2026, making it one of the most significant contributors. This segment’s growth is being driven by its ability to treat complex aneurysms that involve branch arteries near the aortic arch, where conventional EVAR procedures are less effective. Fenestrated grafts allow for customization to patient-specific anatomies, thereby expanding treatment eligibility for high-risk patients who may otherwise have limited surgical options.

Their adaptability in maintaining blood flow to critical branch vessels while repairing aneurysms has enhanced clinical outcomes, supporting wider adoption. Continued innovations in fenestrated graft materials, deployment systems, and imaging-guided placement are further improving procedural safety and efficiency.

The segment is also gaining traction due to rising surgeon expertise, increasing acceptance in tertiary care hospitals, and growing demand for minimally invasive solutions With expanding clinical evidence supporting effectiveness, fenestrated EVAR techniques are expected to strengthen their market position over the coming years.

Insights into the Gender Demographics Segment

The gender demographics segment is anticipated to account for 52.7% of the market revenue share in 2026, making it the leading demographic category. This growth is primarily attributed to the higher prevalence of abdominal aortic aneurysms among men compared to women, which has established men as a dominant treatment group. However, increasing diagnosis among women due to advancements in imaging technologies and awareness campaigns is driving treatment uptake across both genders.

The growing aging population in both male and female categories is further supporting expansion, as aneurysm risk rises significantly with age. Healthcare systems are also emphasizing early detection programs for at-risk individuals, which is improving treatment outcomes and driving greater adoption across genders.

The availability of advanced EVAR solutions tailored for anatomical diversity in men and women is reinforcing market growth As gender-specific research continues to inform surgical practices and device development, the demographics segment is expected to maintain its leadership role, driven by rising prevalence, improved detection, and expanding treatment accessibility.

Market Overview

Endovascular Aneurysm Repair (EVAR) Market Overview

Abnormal enlargement of aorta in the abdomen of a person is a commonly occurring aneurysm in the world. Men and women of all ages are susceptible the incidence of an abdominal aortic aneurysm. Pain arising from such aneurysm can lead to paralysis or even cause death of the patient through cardiac disorders such as arterial stenosis.

Endovascular aneurysm repair (EVAR) is a collective term for all treatments that are directed to surgically cure the aortic aneurysm located in patient’s abdomen. The demand for EVAR devices continues to gain traction across medical organisations such as hospitals and specialty centres.

Analysis of Endovascular Aneurysm Repair (EVAR) Market By Key Countries

Country	CAGR
China	6.5%
India	6.0%
Germany	5.5%
France	5.0%
UK	4.6%
USA	4.1%
Brazil	3.6%

Source: FMI analysis based on primary research and proprietary forecasting model

Country-wise Analysis

The Endovascular Aneurysm Repair (EVAR) Market is expected to register a CAGR of 4.8% during the forecast period, exhibiting varied country level momentum. China leads with the highest CAGR of 6.5%, followed by India at 6.0%. Developed markets such as Germany, France, and the UK continue to expand steadily, while the USA is likely to grow at consistent rates. Brazil posts the lowest CAGR at 3.6%, yet still underscores a broadly positive trajectory for the global Endovascular Aneurysm Repair (EVAR) Market. In 2024, Germany held a dominant revenue in the Western Europe market and is expected to grow with a CAGR of 5.5%. The USA Endovascular Aneurysm Repair (EVAR) Market is estimated to be valued at USD 1.1 billion in 2026 and is anticipated to reach a valuation of USD 1.7 billion by 2036. Sales are projected to rise at a CAGR of 4.1% over the forecast period between 2026 and 2036. While Japan and South Korea markets are estimated to be valued at USD 173.8 million and USD 98.5 million respectively in 2026.

Key Players in the Endovascular Aneurysm Repair (EVAR) Market

• Cardinal Health Inc
• Lombard Medical Inc
• W. L. Gore & Associates Inc
• Medtronic Plc
• Koninklijke Philips N.V.
• Endologix Inc
• Abbott Laboratories
• Cook Medical
• Becton, Dickinson and Company
• Terumo Medical Corporation

Scope of the Report

Metric	Value
Quantitative Units	USD 3.46 Billion to USD 5.53 Billion, at a CAGR of 4.8%
Market Definition	The endovascular aneurysm repair (EVAR) market encompasses medical devices and graft systems used to treat aortic aneurysms through minimally invasive catheter based techniques. Procedures include fen...
Segmentation	Techniques: Fenestrated EVAR, Adjunctive EVARs, Branched EVAR, Percutaneous EVAR, Hybrid Procedures; Demographics: Gender, Age
Regions Covered	North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East & Africa
Countries Covered	China, India, Germany, France, UK, USA, Brazil, and 40 plus countries
Key Companies Profiled	Cardinal Health Inc, Lombard Medical Inc, W. L. Gore & Associates Inc, Medtronic Plc, Koninklijke Philips N.V., Endologix Inc, Abbott Laboratories, Cook Medical, Becton, Dickinson and Company, Terumo Medical Corporation
Forecast Period	2026 to 2036
Approach	Hybrid bottom up methodology combining primary research, supply chain analysis, and proprietary forecasting models.

Endovascular Aneurysm Repair (EVAR) Market by Segments

Techniques:

• Fenestrated EVAR
• Adjunctive EVARs
• Branched EVAR
• Percutaneous EVAR
• Hybrid Procedures

Demographics:

• Gender (Men And Women)
• Age (Paediatric, Adult And Geriatric)

Region:

• North America
  • USA
  • Canada
  • Mexico
• Latin America
  • Brazil
  • Chile
  • Rest of Latin America
• Western Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • Nordic
  • BENELUX
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • Hungary
  • Balkan & Baltic
  • Rest of Eastern Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia & New Zealand
  • Rest of South Asia and Pacific
• Middle East & Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Turkiye
  • South Africa
  • Other African Union
  • Rest of Middle East & Africa

Bibliography

• 1. USA Food and Drug Administration. (2024). Endovascular graft systems: Premarket approval database. FDA.
• 2. European Society for Vascular Surgery. (2024). Clinical practice guidelines for abdominal aortic aneurysm management. ESVS.
• 3. World Health Organization. (2024). Global health estimates: Cardiovascular disease burden. WHO.
• 4. Medtronic Plc. (2025). Annual report 2024: Aortic and peripheral vascular division. Medtronic.
• 5. National Institute for Health and Care Excellence. (2024). Abdominal aortic aneurysm: Diagnosis and management (NICE Guideline NG156 update). NICE.
• 6. Cook Medical. (2025). Fenestrated endovascular graft clinical outcomes registry. Cook Medical.

This bibliography is provided for reader reference. The full Future Market Insights report contains the complete reference list with primary research documentation.